Statement Of Cash Flows [Abstract]

Biofrontera AG - Filing #6520750

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
0 EUR
369,000 EUR
0 EUR
369,000 EUR
0 EUR
44,166 EUR
44,166 EUR
0 EUR
0 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for finance costs
7,259 EUR
44,334 EUR
Adjustments for decrease (increase) in inventories
283,000 EUR
20,000 EUR
Adjustments for decrease (increase) in trade accounts receivable
5,077 EUR
831,000 EUR
Adjustments for decrease (increase) in other operating receivables
590,000 EUR
367,000 EUR
Adjustments for increase (decrease) in trade accounts payable
711,000 EUR
3,204 EUR
Adjustments for increase (decrease) in other operating payables
2,238 EUR
728,000 EUR
Adjustments for depreciation and amortisation expense
791,000 EUR
746,000 EUR
Adjustments for provisions
305,000 EUR
309,000 EUR
Other adjustments for non-cash items
2,450 EUR
569,000 EUR
Adjustments for losses (gains) on disposal of non-current assets
0 EUR
11,000 EUR
Cash flows from (used in) operating activities
1,905 EUR
3,895 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
912,000 EUR
981,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
0 EUR
7,090 EUR
Repayments of borrowings, classified as financing activities
0 EUR
2,031 EUR
Payments of lease liabilities, classified as financing activities
467,000 EUR
453,000 EUR
Interest paid, classified as financing activities
12,000 EUR
198,000 EUR
Cash flows from (used in) financing activities
479,000 EUR
4,344 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
3,296 EUR
532,000 EUR
Cash and cash equivalents
3,080 EUR
6,376 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.